Clorox (CLX) FY2014 results: revenue $5.5 billion, down 0.3% on the year
Clorox Co. (CLX) reported revenue of $5.5 billion for fiscal 2014, the year ended 30 June 2014, down 0.3% on the year before. Net income was $558 million, down 2.4%, and diluted earnings per share $4.23. The figures are the company's own, from the 10-K it filed with the SEC on 14 August 2018.
Revenue
$5.5 billion
-0.3% on the year
FY2008FY2014
Operating margin
n/a
FY2008FY2014
Net income
$558 million
-2.4% on the year
FY2008FY2014
Diluted EPS
$4.23
-1.6% on the year
FY2008FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
5,514
5,533
5,379
-0.3%
Cost of revenue
3,158
3,142
3,107
+0.5%
Gross profit
2,360
2,391
2,272
-1.3%
Gross margin
42.8%
43.2%
42.2%
Research and development
125
130
121
-3.8%
Selling, general and administrative
751
793
783
-5.3%
Interest expense
103
122
125
-15.6%
Pre-tax income
884
n/a
n/a
Income tax
305
279
243
+9.3%
Effective tax rate
34.5%
n/a
n/a
Net income
558
572
541
-2.4%
Net margin
10.1%
10.3%
10.1%
Diluted EPS
$4.23
$4.30
$4.09
-1.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
767
775
612
-1.0%
Capital expenditure
137
190
189
-27.9%
Free cash flow
630
585
423
+7.7%
Free cash flow margin
11.4%
10.6%
7.9%
Cash from investing
-138
-55.0
-277
Cash from financing
-592
-685
-321
Depreciation and amortisation
177
182
178
-2.7%
Share-based compensation
36.0
35.0
27.0
+2.9%
Buybacks
260
128
225
+103.1%
Dividends paid
368
335
315
+9.9%
Dividend per share
$2.87
$2.63
$2.44
+9.1%
Diluted shares, weighted
132m
133m
132m
-0.9%
Shares outstanding at period end
129m
130m
130m
-1.2%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
154
146
-135
+5.5%
Debt
2,313
2,372
2,721
-2.5%
Other liabilities
1,791
1,784
1,769
+0.4%
Total liabilities and equity
4,258
4,302
4,355
-1.0%
Fixed assets
977
1,021
1,081
-4.3%
Goodwill
1,101
1,105
1,112
-0.4%
Intangible assets
611
n/a
n/a
Cash and equivalents
329
299
267
+10.0%
Receivables
546
580
576
-5.9%
Inventory
386
394
384
-2.0%
Other assets
308
903
935
-65.9%
Total assets
4,258
4,302
4,355
-1.0%
10-K for the year ended 30 June 2014, filed 14 August 2018: the filing.